Immunome Inc.
IMNM- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001472012
In the last 90 days, Immunome Inc. insiders filed 0 open-market purchases and 8 sales; 202 institutions reported holding it in 13F filings for Q2 2026, worth $2.50B in total; no superinvestor holds it.
13F holders, Q3 2025
Institutional positions in Immunome Inc. as of Sep 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 153
- +12 vs. Q2 2025
- Shares held
- 91.4M
- +12.0M (+15.1%) vs. Q2 2025
- Total value
- $1.07B
- +$331.8M (+44.9%) vs. Q2 2025
- New holders
- 27
- 64 more added
- Sold out
- 15
- 38 more reduced
1 institution that held it in Q2 2025 haven't filed for Q3 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting IMNM on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 202 | $2.50B |
| Q1 2026 | 202 | $2.54B |
| Q4 2025 | 183 | $2.54B |
| Q3 2025 | 153 | $1.07B |
| Q2 2025 | 142 | $738.7M |
| Q1 2025 | 143 | $518.4M |
| Q4 2024 | 121 | $566.3M |
| Q3 2024 | 115 | $754.7M |
| Q2 2024 | 114 | $578.4M |
| Q1 2024 | 103 | $903.6M |
| Q4 2023 | 57 | $229.9M |
| Q3 2023 | 35 | $19.7M |
| Q2 2023 | 35 | $15.4M |
| Q1 2023 | 30 | $9.34M |
| Q4 2022 | 28 | $4.85M |
| Q3 2022 | 24 | $10.7M |
| Q2 2022 | 26 | $7.78M |
| Q1 2022 | 29 | $15.4M |
| Q4 2021 | 30 | $36.4M |
| Q3 2021 | 35 | $58.3M |
| Q2 2021 | 29 | $41.1M |
| Q1 2021 | 31 | $64.7M |
Institutions, Q3 2025
Shares, value and share of portfolio for each institution holding Immunome Inc.; share changes are against Q2 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| UBS Asset Management Americas Inc | 112,298 | $1.32M | 0.00% | −74,400−39.9% | Reduced |
| Private Capital Advisors, Inc. | 118,046 | $1.38M | 0.15% | −71,798−37.8% | Reduced |
| Gilder Gagnon Howe & Co LLC | 133,112 | $1.56M | 0.02% | +133,112 | New |
| Swiss National Bank | 135,000 | $1.58M | 0.00% | +2,200+1.7% | Added |
| Nuveen, LLC | 145,344 | $1.70M | 0.00% | −96,066−39.8% | Reduced |
| Sphera Funds Management Ltd. | 147,200 | $1.72M | 0.41% | +147,200 | New |
| NEOS Investment Management LLC | 162,186 | $1.90M | 0.01% | +46,755+40.5% | Added |
| Tema ETFs LLC | 162,186 | $1.90M | 0.16% | +46,755+40.5% | Added |
| Handelsbanken Fonder AB | 180,000 | $2.11M | 0.01% | −20,000−10.0% | Reduced |
| AXA Investment Managers S.A. | 180,056 | $2.11M | 0.01% | +180,056 | New |
| Renaissance Technologies LLC | 202,300 | $2.37M | 0.00% | +102,928+103.6% | Added |
| Barclays PLC | 208,513 | $2.44M | 0.00% | −21,360−9.3% | Reduced |
| Goldman Sachs Group Inc | 208,946 | $2.45M | 0.00% | −269,672−56.3% | Reduced |
| Bank of New York Mellon Corp | 217,038 | $2.54M | 0.00% | +11,781+5.7% | Added |
| Wellington Management Group LLP | 254,068 | $2.98M | 0.00% | +42,239+19.9% | Added |
| Kennedy Capital Management, Inc. | 257,426 | $3.01M | 0.07% | +148,074+135.4% | Added |
| Manufacturers Life Insurance Company, The | 290,442 | $3.40M | 0.00% | +9,626+3.4% | Added |
| Dimensional Fund Advisors LP | 338,355 | $3.96M | 0.00% | +233,571+222.9% | Added |
| Parkman Healthcare Partners LLC | 351,131 | $4.11M | 0.45% | +351,131 | New |
| Granahan Investment Management Inc | 426,219 | $4.99M | 0.20% | +33,468+8.5% | Added |
| Sofinnova Investments, Inc. | 436,051 | $5.11M | 0.31% | −342,425−44.0% | Reduced |
| Pivotal bioVenture Partners Investment Advisor LLC | 502,512 | $5.88M | 3.40% | +502,512 | New |
| UBS Group AG | 583,942 | $6.84M | 0.00% | +158,027+37.1% | Added |
| Nan Fung Trinity (HK) Ltd | 592,103 | $6.93M | 0.69% | +43,253+7.9% | Added |
| Charles Schwab Investment Management Inc | 663,612 | $7.77M | 0.00% | +23,363+3.6% | Added |
| Marshall Wace, LLP | 692,179 | $8.11M | 0.01% | −605,573−46.7% | Reduced |
| Driehaus Capital Management LLC | 696,551 | $8.16M | 0.06% | +475,551+215.2% | Added |
| TD Asset Management Inc | 701,280 | $8.21M | 0.01% | +95,750+15.8% | Added |
| Northern Trust Corp | 706,515 | $8.27M | 0.00% | +14,958+2.2% | Added |
| Janus Henderson Group PLC | 763,175 | $8.94M | 0.00% | −277,239−26.6% | Reduced |
| Citadel Advisors LLC | 841,138 | $9.85M | 0.01% | +841,138 | New |
| Candriam Luxembourg S.C.A. | 859,527 | $10.1M | 0.05% | +541,441+170.2% | Added |
| Toronto Dominion Bank | 1,036,056 | $12.1M | 0.02% | −1,049,644−50.3% | Reduced |
| Caption Management, LLC | 1,040,700 | $12.2M | 0.71% | +1,040,700 | New |
| Polar Capital Holdings Plc | 1,058,776 | $12.4M | 0.06% | +58,776+5.9% | Added |
| Principal Financial Group Inc | 1,104,938 | $12.9M | 0.01% | +762,147+222.3% | Added |
| Woodline Partners LP | 1,274,729 | $14.9M | 0.07% | −383,934−23.1% | Reduced |
| Readystate Asset Management LP | 1,318,290 | $15.4M | 0.75% | −35,296−2.6% | Reduced |
| Morgan Stanley | 1,833,818 | $21.5M | 0.00% | +1,429,461+353.5% | Added |
| Geode Capital Management, LLC | 1,894,575 | $22.2M | 0.00% | +33,995+1.8% | Added |
| Jefferies Financial Group Inc. | 2,100,000 | $24.6M | 0.23% | +14,340+0.7% | Added |
| State Street Corp | 2,803,973 | $32.8M | 0.00% | +283,057+11.2% | Added |
| Primecap Management Co | 3,018,009 | $35.3M | 0.03% | −2,201−0.1% | Reduced |
| Opaleye Management Inc. | 3,185,000 | $37.3M | 5.27% | −344,581−9.8% | Reduced |
| Price T Rowe Associates Inc | 3,742,770 | $43.8M | 0.00% | +760,690+25.5% | Added |
| EcoR1 Capital, LLC | 4,079,415 | $47.8M | 2.30% | 00.0% | Unchanged |
| Enavate Sciences GP, LLC | 4,768,583 | $55.8M | 17.05% | 00.0% | Unchanged |
| Point72 Asset Management, L.P. | 4,824,504 | $56.5M | 0.12% | +138,701+3.0% | Added |
| Vanguard Group Inc | 4,893,626 | $57.3M | 0.00% | +368,674+8.1% | Added |
| Redmile Group, LLC | 5,023,385 | $58.8M | 5.72% | +151,160+3.1% | Added |
| BlackRock, Inc. | 5,822,736 | $68.2M | 0.00% | +52,044+0.9% | Added |
| T. Rowe Price Investment Management, Inc. | 8,418,163 | $98.6M | 0.06% | +142,906+1.7% | Added |
| FMR LLC | 13,056,709 | $152.9M | 0.01% | +6,889,043+111.7% | Added |
| Natixis | 0 | $0 | 0.00% | −229,305−100.0% | Sold out |
| AXA S.A. | 0 | $0 | 0.00% | −179,519−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −109,754−100.0% | Sold out |
| Y-Intercept (Hong Kong) Ltd | 0 | $0 | 0.00% | −85,227−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −81,873−100.0% | Sold out |
| Main Management ETF Advisors, LLC | 0 | $0 | 0.00% | −76,944−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −26,654−100.0% | Sold out |
| Cantor Fitzgerald, L. P. | 0 | $0 | 0.00% | −21,000−100.0% | Sold out |
| Man Group plc | 0 | $0 | 0.00% | −20,614−100.0% | Sold out |
| Whalen Wealth Management Inc. | 0 | $0 | 0.00% | −13,722−100.0% | Sold out |
| Verition Fund Management LLC | 0 | $0 | 0.00% | −12,875−100.0% | Sold out |
| SummitTX Capital, L.P. | 0 | $0 | 0.00% | −10,695−100.0% | Sold out |
| Caitong International Asset Management Co., Ltd | 0 | $0 | 0.00% | −610−100.0% | Sold out |
| US Bancorp | 0 | $0 | 0.00% | −21−100.0% | Sold out |
| EverSource Wealth Advisors, LLC | 0 | $0 | 0.00% | −8−100.0% | Sold out |
| Northeast Financial Consultants Inc | – | – | – | – | Not filed |